Phase Ib study of anlotinib in combination with <scp>anti‐PD‐L1</scp> antibody (<scp>TQB2450</scp>) in patients with advanced acral melanoma
2023 · Journal of the European Academy of Dermatology and Venereology · 11 citations
https://doi.org/10.1111/jdv.19467